News
Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...
Robitussin owes some cold sufferers money as part of a class-action settlement. The cough medicine brand has agreed to pay $4.5 million to resolve claims that it duped consumers by marketing its ...
The deadline to get money back as part of a $4.5 million class action settlement involving certain Robitussin products is ...
Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised ...
GlaxoSmithKline found that the cups for Children's Robitussin Honey cough syrup were missing lines for the 5-milliliter and 10-milliliter graduations and the cups for Children's Dimetapp were ...
In the US, the maker of Robitussin cough syrup is recalling several products containing honey due to contamination. If you're someone reaching for cough syrups reguarly during cold spells you're ...
Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results